Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,275,351 papers from all fields of science
Search
Sign In
Create Free Account
diabetic macular edema
Known as:
diabetic macular oedema
, edema diabetic macular
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Diabetic retinal edema
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Daniel S. Kermany
,
Daniel S. Kermany
,
+44 authors
Kang Zhang
Cell
2018
Corpus ID: 3516426
Highly Cited
2016
Highly Cited
2016
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.
Varun Gulshan
,
L. Peng
,
+12 authors
D. Webster
Journal of the American Medical Association (JAMA…
2016
Corpus ID: 26657811
Importance Deep learning is a family of computational methods that allow an algorithm to program itself by learning from a large…
Expand
Highly Cited
2015
Highly Cited
2015
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
J. Wells
,
A. Glassman
,
+14 authors
R. Beck
New England Journal of Medicine
2015
Corpus ID: 32119434
BACKGROUND The relative efficacy and safety of intravitreous aflibercept, bevacizumab, and ranibizumab in the treatment of…
Expand
Review
2015
Review
2015
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Ryan Lee
,
T. Wong
,
C. Sabanayagam
Eye and Vision
2015
Corpus ID: 3238632
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus…
Expand
Review
2012
Review
2012
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
J. Yau
,
S. Rogers
,
+33 authors
T. Wong
Diabetes Care
2012
Corpus ID: 18395627
OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic…
Expand
Highly Cited
2010
Highly Cited
2010
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
M. Elman
,
L. P. Aiello
,
+10 authors
Jennifer K. Sun
Ophthalmology (Rochester, Minn.)
2010
Corpus ID: 29249316
Review
2003
Review
2003
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C. Wilkinson
,
Frederick L. Ferris
,
+7 authors
Juan T. Verdaguer
Ophthalmology (Rochester, Minn.)
2003
Corpus ID: 45474839
Review
2003
Review
2003
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
T. Ciulla
,
A. Amador
,
B. Zinman
Diabetes Care
2003
Corpus ID: 669398
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of blindness in the working-age population of most…
Expand
Highly Cited
2002
Highly Cited
2002
Intravitreal triamcinolone for refractory diabetic macular edema.
A. Martidis
,
J. Duker
,
+4 authors
C. Baumal
Ophthalmology (Rochester, Minn.)
2002
Corpus ID: 37691250
Highly Cited
1985
Highly Cited
1985
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.
A M A Archives of Ophthalmology
1985
Corpus ID: 43838024
Data from the Early Treatment Diabetic Retinopathy Study (ETDRS) show that focal photocoagulation of "clinically significant…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE